Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapastinel for MDD and Suicidality
NCT03352453Phase 2Terminated
- Sponsor
- Allergan
- Start
- Dec 2017
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
A Phase 2 trial of rapastinel in major depressive disorder (MDD), sponsored by Allergan. Started Dec 2017; status: terminated.
02
Drugs
rapastinel
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03352453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03352453.